---
title: "Sucrosomia Vitamin D appears to be 2 X more bio-available– RCT"
slug: "sucrosomia-vitamin-d-appears-to-be-2-x-more-bio-available-rct"
aliases:
  - "/Sucrosomia+Vitamin+D+appears+to+be+2+X+more+bio-available–+RCT+Aug+2023"
  - "/15177"
tiki_page_id: 15177
date: 2024-03-28
categories:
  - "Forms of Vitamin D"
---


<img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/sucrosomial-200k.png" alt="image" width="500">

Note: Horizontal axis IS NOT linear

{{< toc >}}

---

#### A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial

Front. Nutr., 17 August 2023 Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1221685

Aasiya Bano1† Saida Abrar2† Elisa Brilli3 Germano Tarantino3 Ali Akbar Bugti4 Marco Fabbrini5 Gabriele Conti5 Silvia Turroni5 Mahroo Bugti6 Fauzia Afridi7 Shah Mureed8 Hakeem Zada9 Ikram Din Ujjan10 Saadia Ashraf11 Aamir Ghafoor12 Saeed Khan13 Amjad Khan14,15*

 **Second Trial** 

<img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/sucrosomial-bi-weekly.png" alt="image" width="500">

Note: Horizontal axis IS NOT linear

Objective: We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3 preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3 formulations in Vit D-deficient healthy adults.

Methods: In study 1, 25 subjects were randomized to receive a weekly single dose of 200,000 IU of sucrosomial® Vit D3 (n = 12) or chewable tablet Vit D3 (n = 13) for 3 weeks. 

In study 2, 20 subjects were randomized to receive a single dose of 200,000 IU every other week of sucrosomial® Vit D3 (n = 10) or SGC Vit D3 (n = 10) for 6 weeks. Circulatory 25-hydroxyvitamin D3 <span>[25(OH)D]</span> levels were reassessed after 2, 3, and 6 weeks in study 1 and after 4 and 6 weeks in study 2.

Results: In study 1, after 2 weeks, circulatory 25(OH)D levels increased significantly in both Vit D3 treatment groups (p < 0.0001) but improved markedly in the sucrosomial® Vit D3 group, with no further considerable change after 3 and 6 weeks in both groups. Overall, at all three follow-ups, sucrosomial® Vit D3 treatment achieved significantly higher and sustained 25(OH)D levels (p < 0.001). In study 2, after 4 weeks, both Vit D3 treatment groups showed significant improvement in circulatory 25(OH)D levels (p < 0.0001) but substantially higher in the sucrosomial® group with statistically significant differences between the two treatment groups (p = 0.02). At the 6-week follow-up, only subjects in the sucrosomial® Vit D3 group showed a further increase in circulatory 25(OH)D levels (p = 0.049), but no further significant changes in the levels of the SGC Vit D3 group (p = 0.062), showing a statistically significant difference between the two treatment groups (p = 0.002). The Vit D3 treatment was well tolerated by all participants, and no treatment-emergent effects or serious adverse events were reported.

Conclusion: Our results suggest that the sucrosomial® Vit D3 preparation absorbs efficiently in the GI system, achieving adequately higher and sustained circulatory Vit D levels in VDD, and thus can effectively contribute to the body protection against VDD-associated health conditions.

Clinical trial registration: clinicaltrials.gov, identifier: NCT05706259.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/sucrosomial-compresspdf.pdf">Download the PDF from VitaminDWiki </a>** 

---

##### 55 References

1. Bikle Daniel D.  **vitamin**  D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. [doi: 10.1016/j.chembiol.2013.12.016](https://doi.org/10.1016/j.chembiol.2013.12.016)

1. Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al.  **vitamin**  D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of  **vitamin**  D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. [doi: 10.1080/10408363.2022.2070595](https://doi.org/10.1080/10408363.2022.2070595)

1. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C.  **vitamin**  D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. [doi: 10.1016/j.coph.2010.04.001](https://doi.org/10.1016/j.coph.2010.04.001)

1. Lagishetty V, Liu NQ, Hewison M.  **vitamin**  D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. [doi: 10.1016/j.mce.2011.04.015](https://doi.org/10.1016/j.mce.2011.04.015)

1. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al.  **vitamin**  D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. [doi: 10.1016/j.jsbmb.2017.01.021](https://doi.org/10.1016/j.jsbmb.2017.01.021)

1. Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with  **vitamin**  D deficiency. Nutrition. (2021) 84:111106. [doi: 10.1016/j.nut.2020.111106](https://doi.org/10.1016/j.nut.2020.111106)

1. Ao T, Kikuta J, Ishii M. The effects of  **vitamin**  D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. [doi: 10.3390/biom11111624](https://doi.org/10.3390/biom11111624)

1. Charoenngam N, Holick MF. Immunologic effects of **vitamin**  D on human health and disease. Nutrients. (2020) 12:97. [doi: 10.3390/nu12072097](https://doi.org/10.3390/nu12072097)

1. Gois PHF, Ferreira D, Olenski S, Seguro AC.  **vitamin**  D and infectious diseases:	simple bystander or contributing factor? Nutrients. (2017) 9:651. [doi: 10.3390/nu9070651](https://doi.org/10.3390/nu9070651)

1. Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al.  **vitamin**  D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. [doi: 10.3390/tropicalmed8010043](https://doi.org/10.3390/tropicalmed8010043)

1. L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH.  **vitamin**  D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. [doi: 10.1002/jbm4.10405](https://doi.org/10.1002/jbm4.10405)

1. Thacher TD, Clarke BL.  **vitamin**  D insufficiency. Mayo ClinProc. (2011) 86:50­60. [doi: 10.4065/mcp.2010.0567](https://doi.org/10.4065/mcp.2010.0567)

1. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al.  **vitamin**  D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. [doi: 10.1038/s41430-020-0558-y](https://doi.org/10.1038/s41430-020-0558-y)

1. Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current  **vitamin**  D status in european and middle east countries and strategies to prevent  **vitamin**  d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. [doi: 10.1530/EJE-18-0736](https://doi.org/10.1530/EJE-18-0736)

1. Holick MF.  **vitamin**  D deficiency. N Engl J Med. (2007) 357:266­81. [doi: 10.1056/NEJMra070553](https://doi.org/10.1056/NEJMra070553)

1. Nair R, Maseeh A.  **vitamin**  D: the “sunshine"  **vitamin** . J Pharmacol Pharmacother. (2012) 3:118-26. [doi: 10.4103/0976-500X.95506](https://doi.org/10.4103/0976-500X.95506)

1. Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of  **vitamin**  D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. [doi: 10.1586/17512433.2016.1122519](https://doi.org/10.1586/17512433.2016.1122519)

1. Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal  **vitamin**  D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. [doi: 10.1007/s00198-010-1467-z](https://doi.org/10.1007/s00198-010-1467-z)

1. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF.  **vitamin**  D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. [doi: 10.1093/ajcn/42.4.644](https://doi.org/10.1093/ajcn/42.4.644)

1. Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for  **vitamin**  d3 supplementation. Molecules. (2020) 25:851. [doi: 10.3390/molecules25245851](https://doi.org/10.3390/molecules25245851)

1. Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with  **vitamin**  d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. [doi: 10.3390/nu12061553](https://doi.org/10.3390/nu12061553)

1. Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of  **vitamin**  D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. [doi: 10.1177/0148607116629673](https://doi.org/10.1177/0148607116629673)

1. Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral  **vitamin**  D(3) and calcifediol. Bone. (2014) 59:14­9. [doi: 10.1016/j.bone.2013.10.014](https://doi.org/10.1016/j.bone.2013.10.014)

1. Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of  **vitamin**  D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. [doi: 10.3390/nu11030703](https://doi.org/10.3390/nu11030703)

1. Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new  **vitamin**  D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. [doi: 10.1007/s40261](https://doi.org/10.1007/s40261) -021-01113-7

1. Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of  **vitamin**  D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. [doi: 10.1186/s12937-015-0105-1](https://doi.org/10.1186/s12937-015-0105-1)

1. Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of  **vitamin**  D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. [doi: 10.3390/nu11051023](https://doi.org/10.3390/nu11051023)

1. Maurya VK, Aggarwal M. Factors influencing the absorption of  **vitamin**  D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. [doi: 10.1007/s13197-017-2840-0](https://doi.org/10.1007/s13197-017-2840-0)

1. Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M.  **sucrosomial** (®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. [doi: 10.3390/ph11040097](https://doi.org/10.3390/ph11040097)

1. Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. [doi: 10.1111/j.1467-9868.2010.00746.x](https://doi.org/10.1111/j.1467-9868.2010.00746.x)

1. R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).

1. Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).

1. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF.  **vitamin**  D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. [doi: 10.1007/s001980050058](https://doi.org/10.1007/s001980050058)

1. Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G.  **sucrosomial**  technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. [doi: 10.1182/blood.V128.22.3618.3618](https://doi.org/10.1182/blood.V128.22.3618.3618)

1. Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing  **vitamin**  D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. [doi: 10.3390/nutraceuticals3020023](https://doi.org/10.3390/nutraceuticals3020023)

1. Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of  **sucrosomial** (®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. [doi: 10.3390/ijms19092722](https://doi.org/10.3390/ijms19092722)

1. Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. [doi: 10.1271/bbb.60306](https://doi.org/10.1271/bbb.60306)

1. Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. [doi: 10.3109/02652049809006840](https://doi.org/10.3109/02652049809006840)

1. Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral  **sucrosomial**  iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. [doi: 10.3390/nu130](https://doi.org/10.3390/nu130) 20608

1. Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.

1. Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy **vitamin**  D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. [doi: 10.1016/S0022-3476(79)](https://doi.org/10.1016/S0022-3476(79)) 80346-7

1. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH.  **vitamin**  D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. [doi: 10.1016/S0016-5085(82)80135-2](https://doi.org/10.1016/S0016-5085(82)80135-2)

1. Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. [doi: 10.1016/S0140-6736(78)](https://doi.org/10.1016/S0140-6736(78)) 90358-6

1. Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased  **vitamin**  D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. [doi: 10.1016/S0022-3476(82)80031-0](https://doi.org/10.1016/S0022-3476(82)80031-0)

1. Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of  **vitamin**  D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. [doi: 10.3109/00365528209182066](https://doi.org/10.3109/00365528209182066)

1. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy **vitamin**  D3 treatment. Gastroenterology. (1982) 83:97-102. [doi: 10.1016/S0016-5085(82)80291-6](https://doi.org/10.1016/S0016-5085(82)80291-6)

1. Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A.  **vitamin**  D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. [doi: 10.1007/s40519-016-0312-6](https://doi.org/10.1007/s40519-016-0312-6)

1. Gatti D, Idolazzi L, Fassio A.  **vitamin**  D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.

1. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al.  **vitamin**  D supplementation to prevent acute respiratory tract infections:	systematic review and meta-analysis of individual participant data. BMJ. (2017)	356:i6583. [doi:	10.1136/bmj.i6583](https://doi.org/10.1136/bmj.i6583)


<pre style="background-color: #e0e0e0; white-space: pre-wrap;">
<code class="language-text">
Markdown:
--------
&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/png/sucrosomial-200k.png&quot; alt=&quot;image&quot; width=&quot;500&quot;&gt;

Note: Horizontal axis IS NOT linear

{{&lt; toc &gt;}}

---

#### A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial

Front. Nutr., 17 August 2023 Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1221685

Aasiya Bano1† Saida Abrar2† Elisa Brilli3 Germano Tarantino3 Ali Akbar Bugti4 Marco Fabbrini5 Gabriele Conti5 Silvia Turroni5 Mahroo Bugti6 Fauzia Afridi7 Shah Mureed8 Hakeem Zada9 Ikram Din Ujjan10 Saadia Ashraf11 Aamir Ghafoor12 Saeed Khan13 Amjad Khan14,15*

 **Second Trial** 

&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/png/sucrosomial-bi-weekly.png&quot; alt=&quot;image&quot; width=&quot;500&quot;&gt;

Note: Horizontal axis IS NOT linear

Objective: We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3 preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3 formulations in Vit D-deficient healthy adults.

Methods: In study 1, 25 subjects were randomized to receive a weekly single dose of 200,000 IU of sucrosomial® Vit D3 (n = 12) or chewable tablet Vit D3 (n = 13) for 3 weeks. 

In study 2, 20 subjects were randomized to receive a single dose of 200,000 IU every other week of sucrosomial® Vit D3 (n = 10) or SGC Vit D3 (n = 10) for 6 weeks. Circulatory 25-hydroxyvitamin D3 &lt;span&gt;[25(OH)D]&lt;/span&gt; levels were reassessed after 2, 3, and 6 weeks in study 1 and after 4 and 6 weeks in study 2.

Results: In study 1, after 2 weeks, circulatory 25(OH)D levels increased significantly in both Vit D3 treatment groups (p &lt; 0.0001) but improved markedly in the sucrosomial® Vit D3 group, with no further considerable change after 3 and 6 weeks in both groups. Overall, at all three follow-ups, sucrosomial® Vit D3 treatment achieved significantly higher and sustained 25(OH)D levels (p &lt; 0.001). In study 2, after 4 weeks, both Vit D3 treatment groups showed significant improvement in circulatory 25(OH)D levels (p &lt; 0.0001) but substantially higher in the sucrosomial® group with statistically significant differences between the two treatment groups (p = 0.02). At the 6-week follow-up, only subjects in the sucrosomial® Vit D3 group showed a further increase in circulatory 25(OH)D levels (p = 0.049), but no further significant changes in the levels of the SGC Vit D3 group (p = 0.062), showing a statistically significant difference between the two treatment groups (p = 0.002). The Vit D3 treatment was well tolerated by all participants, and no treatment-emergent effects or serious adverse events were reported.

Conclusion: Our results suggest that the sucrosomial® Vit D3 preparation absorbs efficiently in the GI system, achieving adequately higher and sustained circulatory Vit D levels in VDD, and thus can effectively contribute to the body protection against VDD-associated health conditions.

Clinical trial registration: clinicaltrials.gov, identifier: NCT05706259.

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/sucrosomial-compresspdf.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 

---

##### 55 References

1. Bikle Daniel D.  **vitamin**  D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. [doi: 10.1016/j.chembiol.2013.12.016](https://doi.org/10.1016/j.chembiol.2013.12.016)

1. Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al.  **vitamin**  D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of  **vitamin**  D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. [doi: 10.1080/10408363.2022.2070595](https://doi.org/10.1080/10408363.2022.2070595)

1. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C.  **vitamin**  D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. [doi: 10.1016/j.coph.2010.04.001](https://doi.org/10.1016/j.coph.2010.04.001)

1. Lagishetty V, Liu NQ, Hewison M.  **vitamin**  D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. [doi: 10.1016/j.mce.2011.04.015](https://doi.org/10.1016/j.mce.2011.04.015)

1. Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al.  **vitamin**  D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. [doi: 10.1016/j.jsbmb.2017.01.021](https://doi.org/10.1016/j.jsbmb.2017.01.021)

1. Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with  **vitamin**  D deficiency. Nutrition. (2021) 84:111106. [doi: 10.1016/j.nut.2020.111106](https://doi.org/10.1016/j.nut.2020.111106)

1. Ao T, Kikuta J, Ishii M. The effects of  **vitamin**  D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. [doi: 10.3390/biom11111624](https://doi.org/10.3390/biom11111624)

1. Charoenngam N, Holick MF. Immunologic effects of **vitamin**  D on human health and disease. Nutrients. (2020) 12:97. [doi: 10.3390/nu12072097](https://doi.org/10.3390/nu12072097)

1. Gois PHF, Ferreira D, Olenski S, Seguro AC.  **vitamin**  D and infectious diseases:	simple bystander or contributing factor? Nutrients. (2017) 9:651. [doi: 10.3390/nu9070651](https://doi.org/10.3390/nu9070651)

1. Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al.  **vitamin**  D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. [doi: 10.3390/tropicalmed8010043](https://doi.org/10.3390/tropicalmed8010043)

1. L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH.  **vitamin**  D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. [doi: 10.1002/jbm4.10405](https://doi.org/10.1002/jbm4.10405)

1. Thacher TD, Clarke BL.  **vitamin**  D insufficiency. Mayo ClinProc. (2011) 86:50­60. [doi: 10.4065/mcp.2010.0567](https://doi.org/10.4065/mcp.2010.0567)

1. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al.  **vitamin**  D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. [doi: 10.1038/s41430-020-0558-y](https://doi.org/10.1038/s41430-020-0558-y)

1. Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current  **vitamin**  D status in european and middle east countries and strategies to prevent  **vitamin**  d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. [doi: 10.1530/EJE-18-0736](https://doi.org/10.1530/EJE-18-0736)

1. Holick MF.  **vitamin**  D deficiency. N Engl J Med. (2007) 357:266­81. [doi: 10.1056/NEJMra070553](https://doi.org/10.1056/NEJMra070553)

1. Nair R, Maseeh A.  **vitamin**  D: the “sunshine&quot;  **vitamin** . J Pharmacol Pharmacother. (2012) 3:118-26. [doi: 10.4103/0976-500X.95506](https://doi.org/10.4103/0976-500X.95506)

1. Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of  **vitamin**  D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. [doi: 10.1586/17512433.2016.1122519](https://doi.org/10.1586/17512433.2016.1122519)

1. Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal  **vitamin**  D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. [doi: 10.1007/s00198-010-1467-z](https://doi.org/10.1007/s00198-010-1467-z)

1. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF.  **vitamin**  D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. [doi: 10.1093/ajcn/42.4.644](https://doi.org/10.1093/ajcn/42.4.644)

1. Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for  **vitamin**  d3 supplementation. Molecules. (2020) 25:851. [doi: 10.3390/molecules25245851](https://doi.org/10.3390/molecules25245851)

1. Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with  **vitamin**  d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. [doi: 10.3390/nu12061553](https://doi.org/10.3390/nu12061553)

1. Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of  **vitamin**  D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. [doi: 10.1177/0148607116629673](https://doi.org/10.1177/0148607116629673)

1. Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral  **vitamin**  D(3) and calcifediol. Bone. (2014) 59:14­9. [doi: 10.1016/j.bone.2013.10.014](https://doi.org/10.1016/j.bone.2013.10.014)

1. Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of  **vitamin**  D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. [doi: 10.3390/nu11030703](https://doi.org/10.3390/nu11030703)

1. Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new  **vitamin**  D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. [doi: 10.1007/s40261](https://doi.org/10.1007/s40261) -021-01113-7

1. Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of  **vitamin**  D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. [doi: 10.1186/s12937-015-0105-1](https://doi.org/10.1186/s12937-015-0105-1)

1. Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of  **vitamin**  D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. [doi: 10.3390/nu11051023](https://doi.org/10.3390/nu11051023)

1. Maurya VK, Aggarwal M. Factors influencing the absorption of  **vitamin**  D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. [doi: 10.1007/s13197-017-2840-0](https://doi.org/10.1007/s13197-017-2840-0)

1. Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M.  **sucrosomial** (®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. [doi: 10.3390/ph11040097](https://doi.org/10.3390/ph11040097)

1. Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. [doi: 10.1111/j.1467-9868.2010.00746.x](https://doi.org/10.1111/j.1467-9868.2010.00746.x)

1. R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).

1. Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).

1. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF.  **vitamin**  D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. [doi: 10.1007/s001980050058](https://doi.org/10.1007/s001980050058)

1. Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G.  **sucrosomial**  technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. [doi: 10.1182/blood.V128.22.3618.3618](https://doi.org/10.1182/blood.V128.22.3618.3618)

1. Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing  **vitamin**  D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. [doi: 10.3390/nutraceuticals3020023](https://doi.org/10.3390/nutraceuticals3020023)

1. Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of  **sucrosomial** (®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. [doi: 10.3390/ijms19092722](https://doi.org/10.3390/ijms19092722)

1. Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. [doi: 10.1271/bbb.60306](https://doi.org/10.1271/bbb.60306)

1. Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. [doi: 10.3109/02652049809006840](https://doi.org/10.3109/02652049809006840)

1. Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral  **sucrosomial**  iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. [doi: 10.3390/nu130](https://doi.org/10.3390/nu130) 20608

1. Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.

1. Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy **vitamin**  D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. [doi: 10.1016/S0022-3476(79)](https://doi.org/10.1016/S0022-3476(79)) 80346-7

1. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH.  **vitamin**  D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. [doi: 10.1016/S0016-5085(82)80135-2](https://doi.org/10.1016/S0016-5085(82)80135-2)

1. Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. [doi: 10.1016/S0140-6736(78)](https://doi.org/10.1016/S0140-6736(78)) 90358-6

1. Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased  **vitamin**  D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. [doi: 10.1016/S0022-3476(82)80031-0](https://doi.org/10.1016/S0022-3476(82)80031-0)

1. Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of  **vitamin**  D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. [doi: 10.3109/00365528209182066](https://doi.org/10.3109/00365528209182066)

1. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy **vitamin**  D3 treatment. Gastroenterology. (1982) 83:97-102. [doi: 10.1016/S0016-5085(82)80291-6](https://doi.org/10.1016/S0016-5085(82)80291-6)

1. Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A.  **vitamin**  D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. [doi: 10.1007/s40519-016-0312-6](https://doi.org/10.1007/s40519-016-0312-6)

1. Gatti D, Idolazzi L, Fassio A.  **vitamin**  D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.

1. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al.  **vitamin**  D supplementation to prevent acute respiratory tract infections:	systematic review and meta-analysis of individual participant data. BMJ. (2017)	356:i6583. [doi:	10.1136/bmj.i6583](https://doi.org/10.1136/bmj.i6583)


AST Structure:
-------------
├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;21032&quot; width=&quot;500&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;21032&quot; width=&quot;500&quot;
│   │   type: attId
│   │   attId: 21032
│   │   width: 500├── TextNode
│   full_match: `\nNote: Horizontal axis IS NOT linear\n\n`
│   inner_content: `\nNote: Horizontal axis IS NOT linear\n\n`├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial`
│   inner_content: `A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial`
│   │   inner_content: `A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial`├── TextNode
│   full_match: `\nFront. Nutr., 17 August 2023 Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1221685\nAasiya Bano1† Saida Abrar2† Elisa Brilli3 Germano Tarantino3 Ali Akbar Bugti4 Marco Fabbrini5 Gabriele Conti5 Silvia Turroni5 Mahroo Bugti6 Fauzia Afridi7 Shah Mureed8 Hakeem Zada9 Ikram Din Ujjan10 Saadia Ashraf11 Aamir Ghafoor12 Saeed Khan13 Amjad Khan14,15*\n\n`
│   inner_content: `\nFront. Nutr., 17 August 2023 Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1221685\nAasiya Bano1† Saida Abrar2† Elisa Brilli3 Germano Tarantino3 Ali Akbar Bugti4 Marco Fabbrini5 Gabriele Conti5 Silvia Turroni5 Mahroo Bugti6 Fauzia Afridi7 Shah Mureed8 Hakeem Zada9 Ikram Din Ujjan10 Saadia Ashraf11 Aamir Ghafoor12 Saeed Khan13 Amjad Khan14,15*\n\n`├── BoldNode
│   full_match: `__Second Trial__`
│   inner_content: `Second Trial`
│   children:
│   ├── TextNode
│   │   full_match: `Second Trial`
│   │   inner_content: `Second Trial`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;21033&quot; width=&quot;500&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;21033&quot; width=&quot;500&quot;
│   │   type: attId
│   │   attId: 21033
│   │   width: 500├── TextNode
│   full_match: `\nNote: Horizontal axis IS NOT linear\nObjective: We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3 preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3 formulations in Vit D-deficient healthy adults.\n\nMethods: In study 1, 25 subjects were randomized to receive a weekly single dose of 200,000 IU of sucrosomial® Vit D3 (n = 12) or chewable tablet Vit D3 (n = 13) for 3 weeks. \nIn study 2, 20 subjects were randomized to receive a single dose of 200,000 IU every other week of sucrosomial® Vit D3 (n = 10) or SGC Vit D3 (n = 10) for 6 weeks. Circulatory 25-hydroxyvitamin D3 `
│   inner_content: `\nNote: Horizontal axis IS NOT linear\nObjective: We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3 preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3 formulations in Vit D-deficient healthy adults.\n\nMethods: In study 1, 25 subjects were randomized to receive a weekly single dose of 200,000 IU of sucrosomial® Vit D3 (n = 12) or chewable tablet Vit D3 (n = 13) for 3 weeks. \nIn study 2, 20 subjects were randomized to receive a single dose of 200,000 IU every other week of sucrosomial® Vit D3 (n = 10) or SGC Vit D3 (n = 10) for 6 weeks. Circulatory 25-hydroxyvitamin D3 `├── LinkNode
│   full_match: `[25(OH)D]`
│   inner_content: `25(OH)D`
│   url: `25(OH)D`
│   children:
│   ├── TextNode
│   │   full_match: `25(OH)D`
│   │   inner_content: `25(OH)D`├── TextNode
│   full_match: ` levels were reassessed after 2, 3, and 6 weeks in study 1 and after 4 and 6 weeks in study 2.\n\nResults: In study 1, after 2 weeks, circulatory 25(OH)D levels increased significantly in both Vit D3 treatment groups (p &lt; 0.0001) but improved markedly in the sucrosomial® Vit D3 group, with no further considerable change after 3 and 6 weeks in both groups. Overall, at all three follow-ups, sucrosomial® Vit D3 treatment achieved significantly higher and sustained 25(OH)D levels (p &lt; 0.001). In study 2, after 4 weeks, both Vit D3 treatment groups showed significant improvement in circulatory 25(OH)D levels (p &lt; 0.0001) but substantially higher in the sucrosomial® group with statistically significant differences between the two treatment groups (p = 0.02). At the 6-week follow-up, only subjects in the sucrosomial® Vit D3 group showed a further increase in circulatory 25(OH)D levels (p = 0.049), but no further significant changes in the levels of the SGC Vit D3 group (p = 0.062), showing a statistically significant difference between the two treatment groups (p = 0.002). The Vit D3 treatment was well tolerated by all participants, and no treatment-emergent effects or serious adverse events were reported.\n\nConclusion: Our results suggest that the sucrosomial® Vit D3 preparation absorbs efficiently in the GI system, achieving adequately higher and sustained circulatory Vit D levels in VDD, and thus can effectively contribute to the body protection against VDD-associated health conditions.\n\nClinical trial registration: clinicaltrials.gov, identifier: NCT05706259.\n`
│   inner_content: ` levels were reassessed after 2, 3, and 6 weeks in study 1 and after 4 and 6 weeks in study 2.\n\nResults: In study 1, after 2 weeks, circulatory 25(OH)D levels increased significantly in both Vit D3 treatment groups (p &lt; 0.0001) but improved markedly in the sucrosomial® Vit D3 group, with no further considerable change after 3 and 6 weeks in both groups. Overall, at all three follow-ups, sucrosomial® Vit D3 treatment achieved significantly higher and sustained 25(OH)D levels (p &lt; 0.001). In study 2, after 4 weeks, both Vit D3 treatment groups showed significant improvement in circulatory 25(OH)D levels (p &lt; 0.0001) but substantially higher in the sucrosomial® group with statistically significant differences between the two treatment groups (p = 0.02). At the 6-week follow-up, only subjects in the sucrosomial® Vit D3 group showed a further increase in circulatory 25(OH)D levels (p = 0.049), but no further significant changes in the levels of the SGC Vit D3 group (p = 0.062), showing a statistically significant difference between the two treatment groups (p = 0.002). The Vit D3 treatment was well tolerated by all participants, and no treatment-emergent effects or serious adverse events were reported.\n\nConclusion: Our results suggest that the sucrosomial® Vit D3 preparation absorbs efficiently in the GI system, achieving adequately higher and sustained circulatory Vit D levels in VDD, and thus can effectively contribute to the body protection against VDD-associated health conditions.\n\nClinical trial registration: clinicaltrials.gov, identifier: NCT05706259.\n`├── FontNode
│   full_match: `{FONT(size=&quot;18&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;18&quot;
│   │   size: 18
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 21031
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!55 References`
│   inner_content: `55 References`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `55 References`
│   │   inner_content: `55 References`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bikle Daniel D. __vitamin__ D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. doi: 10.1016/j.chembiol.2013.12.016`
│   inner_content: `Bikle Daniel D. __vitamin__ D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. doi: 10.1016/j.chembiol.2013.12.016`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bikle Daniel D. `
│   │   inner_content: `Bikle Daniel D. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. `
│   │   inner_content: ` D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.chembiol.2013.12.016`
│   │   inner_content: `10.1016/j.chembiol.2013.12.016`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al. __vitamin__ D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of __vitamin__ D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. doi: 10.1080/10408363.2022.2070595`
│   inner_content: `Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al. __vitamin__ D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of __vitamin__ D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. doi: 10.1080/10408363.2022.2070595`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al. `
│   │   inner_content: `Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of `
│   │   inner_content: ` D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. `
│   │   inner_content: ` D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1080/10408363.2022.2070595`
│   │   inner_content: `10.1080/10408363.2022.2070595`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. doi: 10.1016/j.coph.2010.04.001`
│   inner_content: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. doi: 10.1016/j.coph.2010.04.001`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. `
│   │   inner_content: `Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. `
│   │   inner_content: ` D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.coph.2010.04.001`
│   │   inner_content: `10.1016/j.coph.2010.04.001`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lagishetty V, Liu NQ, Hewison M. __vitamin__ D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. doi: 10.1016/j.mce.2011.04.015`
│   inner_content: `Lagishetty V, Liu NQ, Hewison M. __vitamin__ D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. doi: 10.1016/j.mce.2011.04.015`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lagishetty V, Liu NQ, Hewison M. `
│   │   inner_content: `Lagishetty V, Liu NQ, Hewison M. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. `
│   │   inner_content: ` D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.mce.2011.04.015`
│   │   inner_content: `10.1016/j.mce.2011.04.015`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. __vitamin__ D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. doi: 10.1016/j.jsbmb.2017.01.021`
│   inner_content: `Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. __vitamin__ D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. doi: 10.1016/j.jsbmb.2017.01.021`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. `
│   │   inner_content: `Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. `
│   │   inner_content: ` D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.jsbmb.2017.01.021`
│   │   inner_content: `10.1016/j.jsbmb.2017.01.021`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with __vitamin__ D deficiency. Nutrition. (2021) 84:111106. doi: 10.1016/j.nut.2020.111106`
│   inner_content: `Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with __vitamin__ D deficiency. Nutrition. (2021) 84:111106. doi: 10.1016/j.nut.2020.111106`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with `
│   │   inner_content: `Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency. Nutrition. (2021) 84:111106. `
│   │   inner_content: ` D deficiency. Nutrition. (2021) 84:111106. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.nut.2020.111106`
│   │   inner_content: `10.1016/j.nut.2020.111106`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Ao T, Kikuta J, Ishii M. The effects of __vitamin__ D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. doi: 10.3390/biom11111624`
│   inner_content: `Ao T, Kikuta J, Ishii M. The effects of __vitamin__ D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. doi: 10.3390/biom11111624`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ao T, Kikuta J, Ishii M. The effects of `
│   │   inner_content: `Ao T, Kikuta J, Ishii M. The effects of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. `
│   │   inner_content: ` D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/biom11111624`
│   │   inner_content: `10.3390/biom11111624`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Charoenngam N, Holick MF. Immunologic effects of__vitamin__ D on human health and disease. Nutrients. (2020) 12:97. doi: 10.3390/nu12072097`
│   inner_content: `Charoenngam N, Holick MF. Immunologic effects of__vitamin__ D on human health and disease. Nutrients. (2020) 12:97. doi: 10.3390/nu12072097`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Charoenngam N, Holick MF. Immunologic effects of`
│   │   inner_content: `Charoenngam N, Holick MF. Immunologic effects of`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D on human health and disease. Nutrients. (2020) 12:97. `
│   │   inner_content: ` D on human health and disease. Nutrients. (2020) 12:97. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu12072097`
│   │   inner_content: `10.3390/nu12072097`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gois PHF, Ferreira D, Olenski S, Seguro AC. __vitamin__ D and infectious diseases:\tsimple bystander or contributing factor? Nutrients. (2017) 9:651. doi: 10.3390/nu9070651`
│   inner_content: `Gois PHF, Ferreira D, Olenski S, Seguro AC. __vitamin__ D and infectious diseases:\tsimple bystander or contributing factor? Nutrients. (2017) 9:651. doi: 10.3390/nu9070651`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gois PHF, Ferreira D, Olenski S, Seguro AC. `
│   │   inner_content: `Gois PHF, Ferreira D, Olenski S, Seguro AC. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and infectious diseases:\tsimple bystander or contributing factor? Nutrients. (2017) 9:651. `
│   │   inner_content: ` D and infectious diseases:\tsimple bystander or contributing factor? Nutrients. (2017) 9:651. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu9070651`
│   │   inner_content: `10.3390/nu9070651`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al. __vitamin__ D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. doi: 10.3390/tropicalmed8010043`
│   inner_content: `Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al. __vitamin__ D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. doi: 10.3390/tropicalmed8010043`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al. `
│   │   inner_content: `Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. `
│   │   inner_content: ` D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/tropicalmed8010043`
│   │   inner_content: `10.3390/tropicalmed8010043`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. __vitamin__ D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. doi: 10.1002/jbm4.10405`
│   inner_content: `L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. __vitamin__ D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. doi: 10.1002/jbm4.10405`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. `
│   │   inner_content: `L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. `
│   │   inner_content: ` D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1002/jbm4.10405`
│   │   inner_content: `10.1002/jbm4.10405`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Thacher TD, Clarke BL. __vitamin__ D insufficiency. Mayo ClinProc. (2011) 86:50­60. doi: 10.4065/mcp.2010.0567`
│   inner_content: `Thacher TD, Clarke BL. __vitamin__ D insufficiency. Mayo ClinProc. (2011) 86:50­60. doi: 10.4065/mcp.2010.0567`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Thacher TD, Clarke BL. `
│   │   inner_content: `Thacher TD, Clarke BL. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D insufficiency. Mayo ClinProc. (2011) 86:50­60. `
│   │   inner_content: ` D insufficiency. Mayo ClinProc. (2011) 86:50­60. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.4065/mcp.2010.0567`
│   │   inner_content: `10.4065/mcp.2010.0567`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al. __vitamin__ D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. doi: 10.1038/s41430-020-0558-y`
│   inner_content: `Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al. __vitamin__ D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. doi: 10.1038/s41430-020-0558-y`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al. `
│   │   inner_content: `Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. `
│   │   inner_content: ` D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1038/s41430-020-0558-y`
│   │   inner_content: `10.1038/s41430-020-0558-y`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current __vitamin__ D status in european and middle east countries and strategies to prevent __vitamin__ d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. doi: 10.1530/EJE-18-0736`
│   inner_content: `Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current __vitamin__ D status in european and middle east countries and strategies to prevent __vitamin__ d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. doi: 10.1530/EJE-18-0736`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current `
│   │   inner_content: `Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status in european and middle east countries and strategies to prevent `
│   │   inner_content: ` D status in european and middle east countries and strategies to prevent `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. `
│   │   inner_content: ` d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1530/EJE-18-0736`
│   │   inner_content: `10.1530/EJE-18-0736`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holick MF. __vitamin__ D deficiency. N Engl J Med. (2007) 357:266­81. doi: 10.1056/NEJMra070553`
│   inner_content: `Holick MF. __vitamin__ D deficiency. N Engl J Med. (2007) 357:266­81. doi: 10.1056/NEJMra070553`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick MF. `
│   │   inner_content: `Holick MF. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency. N Engl J Med. (2007) 357:266­81. `
│   │   inner_content: ` D deficiency. N Engl J Med. (2007) 357:266­81. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1056/NEJMra070553`
│   │   inner_content: `10.1056/NEJMra070553`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Nair R, Maseeh A. __vitamin__ D: the “sunshine&quot; __vitamin__. J Pharmacol Pharmacother. (2012) 3:118-26. doi: 10.4103/0976-500X.95506`
│   inner_content: `Nair R, Maseeh A. __vitamin__ D: the “sunshine&quot; __vitamin__. J Pharmacol Pharmacother. (2012) 3:118-26. doi: 10.4103/0976-500X.95506`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Nair R, Maseeh A. `
│   │   inner_content: `Nair R, Maseeh A. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: the “sunshine&quot; `
│   │   inner_content: ` D: the “sunshine&quot; `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: `. J Pharmacol Pharmacother. (2012) 3:118-26. `
│   │   inner_content: `. J Pharmacol Pharmacother. (2012) 3:118-26. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.4103/0976-500X.95506`
│   │   inner_content: `10.4103/0976-500X.95506`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of __vitamin__ D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. doi: 10.1586/17512433.2016.1122519`
│   inner_content: `Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of __vitamin__ D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. doi: 10.1586/17512433.2016.1122519`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of `
│   │   inner_content: `Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. `
│   │   inner_content: ` D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1586/17512433.2016.1122519`
│   │   inner_content: `10.1586/17512433.2016.1122519`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal __vitamin__ D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. doi: 10.1007/s00198-010-1467-z`
│   inner_content: `Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal __vitamin__ D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. doi: 10.1007/s00198-010-1467-z`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal `
│   │   inner_content: `Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. `
│   │   inner_content: ` D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1007/s00198-010-1467-z`
│   │   inner_content: `10.1007/s00198-010-1467-z`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. __vitamin__ D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. doi: 10.1093/ajcn/42.4.644`
│   inner_content: `Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. __vitamin__ D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. doi: 10.1093/ajcn/42.4.644`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. `
│   │   inner_content: `Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. `
│   │   inner_content: ` D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1093/ajcn/42.4.644`
│   │   inner_content: `10.1093/ajcn/42.4.644`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for __vitamin__ d3 supplementation. Molecules. (2020) 25:851. doi: 10.3390/molecules25245851`
│   inner_content: `Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for __vitamin__ d3 supplementation. Molecules. (2020) 25:851. doi: 10.3390/molecules25245851`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for `
│   │   inner_content: `Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` d3 supplementation. Molecules. (2020) 25:851. `
│   │   inner_content: ` d3 supplementation. Molecules. (2020) 25:851. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/molecules25245851`
│   │   inner_content: `10.3390/molecules25245851`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with __vitamin__ d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. doi: 10.3390/nu12061553`
│   inner_content: `Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with __vitamin__ d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. doi: 10.3390/nu12061553`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with `
│   │   inner_content: `Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. `
│   │   inner_content: ` d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu12061553`
│   │   inner_content: `10.3390/nu12061553`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of __vitamin__ D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. doi: 10.1177/0148607116629673`
│   inner_content: `Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of __vitamin__ D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. doi: 10.1177/0148607116629673`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of `
│   │   inner_content: `Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. `
│   │   inner_content: ` D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1177/0148607116629673`
│   │   inner_content: `10.1177/0148607116629673`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral __vitamin__ D(3) and calcifediol. Bone. (2014) 59:14­9. doi: 10.1016/j.bone.2013.10.014`
│   inner_content: `Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral __vitamin__ D(3) and calcifediol. Bone. (2014) 59:14­9. doi: 10.1016/j.bone.2013.10.014`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral `
│   │   inner_content: `Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D(3) and calcifediol. Bone. (2014) 59:14­9. `
│   │   inner_content: ` D(3) and calcifediol. Bone. (2014) 59:14­9. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/j.bone.2013.10.014`
│   │   inner_content: `10.1016/j.bone.2013.10.014`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of __vitamin__ D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. doi: 10.3390/nu11030703`
│   inner_content: `Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of __vitamin__ D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. doi: 10.3390/nu11030703`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of `
│   │   inner_content: `Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. `
│   │   inner_content: ` D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu11030703`
│   │   inner_content: `10.3390/nu11030703`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new __vitamin__ D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. doi: 10.1007/s40261 -021-01113-7`
│   inner_content: `Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new __vitamin__ D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. doi: 10.1007/s40261 -021-01113-7`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new `
│   │   inner_content: `Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. `
│   │   inner_content: ` D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1007/s40261`
│   │   inner_content: `10.1007/s40261`
│   ├── TextNode
│   │   full_match: ` -021-01113-7`
│   │   inner_content: ` -021-01113-7`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of __vitamin__ D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. doi: 10.1186/s12937-015-0105-1`
│   inner_content: `Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of __vitamin__ D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. doi: 10.1186/s12937-015-0105-1`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of `
│   │   inner_content: `Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. `
│   │   inner_content: ` D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1186/s12937-015-0105-1`
│   │   inner_content: `10.1186/s12937-015-0105-1`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of __vitamin__ D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. doi: 10.3390/nu11051023`
│   inner_content: `Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of __vitamin__ D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. doi: 10.3390/nu11051023`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of `
│   │   inner_content: `Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. `
│   │   inner_content: ` D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu11051023`
│   │   inner_content: `10.3390/nu11051023`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Maurya VK, Aggarwal M. Factors influencing the absorption of __vitamin__ D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. doi: 10.1007/s13197-017-2840-0`
│   inner_content: `Maurya VK, Aggarwal M. Factors influencing the absorption of __vitamin__ D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. doi: 10.1007/s13197-017-2840-0`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Maurya VK, Aggarwal M. Factors influencing the absorption of `
│   │   inner_content: `Maurya VK, Aggarwal M. Factors influencing the absorption of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. `
│   │   inner_content: ` D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1007/s13197-017-2840-0`
│   │   inner_content: `10.1007/s13197-017-2840-0`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. __sucrosomial__(®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. doi: 10.3390/ph11040097`
│   inner_content: `Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. __sucrosomial__(®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. doi: 10.3390/ph11040097`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. `
│   │   inner_content: `Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. `
│   ├── BoldNode
│   │   full_match: `__sucrosomial__`
│   │   inner_content: `sucrosomial`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `sucrosomial`
│   │   │   inner_content: `sucrosomial`
│   ├── TextNode
│   │   full_match: `(®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. `
│   │   inner_content: `(®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/ph11040097`
│   │   inner_content: `10.3390/ph11040097`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. doi: 10.1111/j.1467-9868.2010.00746.x`
│   inner_content: `Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. doi: 10.1111/j.1467-9868.2010.00746.x`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. `
│   │   inner_content: `Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1111/j.1467-9868.2010.00746.x`
│   │   inner_content: `10.1111/j.1467-9868.2010.00746.x`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).`
│   inner_content: `R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).`
│   │   inner_content: `R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).`
│   inner_content: `Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).`
│   │   inner_content: `Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. __vitamin__ D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. doi: 10.1007/s001980050058`
│   inner_content: `Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. __vitamin__ D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. doi: 10.1007/s001980050058`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. `
│   │   inner_content: `Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. `
│   │   inner_content: ` D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1007/s001980050058`
│   │   inner_content: `10.1007/s001980050058`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G. __sucrosomial__ technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. doi: 10.1182/blood.V128.22.3618.3618`
│   inner_content: `Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G. __sucrosomial__ technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. doi: 10.1182/blood.V128.22.3618.3618`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G. `
│   │   inner_content: `Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G. `
│   ├── BoldNode
│   │   full_match: `__sucrosomial__`
│   │   inner_content: `sucrosomial`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `sucrosomial`
│   │   │   inner_content: `sucrosomial`
│   ├── TextNode
│   │   full_match: ` technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. `
│   │   inner_content: ` technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1182/blood.V128.22.3618.3618`
│   │   inner_content: `10.1182/blood.V128.22.3618.3618`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing __vitamin__ D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. doi: 10.3390/nutraceuticals3020023`
│   inner_content: `Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing __vitamin__ D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. doi: 10.3390/nutraceuticals3020023`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing `
│   │   inner_content: `Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. `
│   │   inner_content: ` D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nutraceuticals3020023`
│   │   inner_content: `10.3390/nutraceuticals3020023`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of __sucrosomial__(®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. doi: 10.3390/ijms19092722`
│   inner_content: `Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of __sucrosomial__(®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. doi: 10.3390/ijms19092722`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of `
│   │   inner_content: `Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of `
│   ├── BoldNode
│   │   full_match: `__sucrosomial__`
│   │   inner_content: `sucrosomial`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `sucrosomial`
│   │   │   inner_content: `sucrosomial`
│   ├── TextNode
│   │   full_match: `(®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. `
│   │   inner_content: `(®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/ijms19092722`
│   │   inner_content: `10.3390/ijms19092722`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. doi: 10.1271/bbb.60306`
│   inner_content: `Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. doi: 10.1271/bbb.60306`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. `
│   │   inner_content: `Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1271/bbb.60306`
│   │   inner_content: `10.1271/bbb.60306`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. doi: 10.3109/02652049809006840`
│   inner_content: `Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. doi: 10.3109/02652049809006840`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. `
│   │   inner_content: `Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3109/02652049809006840`
│   │   inner_content: `10.3109/02652049809006840`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral __sucrosomial__ iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. doi: 10.3390/nu130 20608`
│   inner_content: `Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral __sucrosomial__ iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. doi: 10.3390/nu130 20608`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral `
│   │   inner_content: `Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral `
│   ├── BoldNode
│   │   full_match: `__sucrosomial__`
│   │   inner_content: `sucrosomial`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `sucrosomial`
│   │   │   inner_content: `sucrosomial`
│   ├── TextNode
│   │   full_match: ` iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. `
│   │   inner_content: ` iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3390/nu130`
│   │   inner_content: `10.3390/nu130`
│   ├── TextNode
│   │   full_match: ` 20608`
│   │   inner_content: ` 20608`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.`
│   inner_content: `Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.`
│   │   inner_content: `Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy__vitamin__ D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. doi: 10.1016/S0022-3476(79) 80346-7`
│   inner_content: `Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy__vitamin__ D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. doi: 10.1016/S0022-3476(79) 80346-7`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy`
│   │   inner_content: `Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. `
│   │   inner_content: ` D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/S0022-3476(79)`
│   │   inner_content: `10.1016/S0022-3476(79)`
│   ├── TextNode
│   │   full_match: ` 80346-7`
│   │   inner_content: ` 80346-7`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. __vitamin__ D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. doi: 10.1016/S0016-5085(82)80135-2`
│   inner_content: `Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. __vitamin__ D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. doi: 10.1016/S0016-5085(82)80135-2`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. `
│   │   inner_content: `Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. `
│   │   inner_content: ` D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/S0016-5085(82)80135-2`
│   │   inner_content: `10.1016/S0016-5085(82)80135-2`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. doi: 10.1016/S0140-6736(78) 90358-6`
│   inner_content: `Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. doi: 10.1016/S0140-6736(78) 90358-6`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. `
│   │   inner_content: `Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/S0140-6736(78)`
│   │   inner_content: `10.1016/S0140-6736(78)`
│   ├── TextNode
│   │   full_match: ` 90358-6`
│   │   inner_content: ` 90358-6`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased __vitamin__ D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. doi: 10.1016/S0022-3476(82)80031-0`
│   inner_content: `Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased __vitamin__ D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. doi: 10.1016/S0022-3476(82)80031-0`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased `
│   │   inner_content: `Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. `
│   │   inner_content: ` D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/S0022-3476(82)80031-0`
│   │   inner_content: `10.1016/S0022-3476(82)80031-0`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of __vitamin__ D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. doi: 10.3109/00365528209182066`
│   inner_content: `Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of __vitamin__ D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. doi: 10.3109/00365528209182066`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of `
│   │   inner_content: `Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. `
│   │   inner_content: ` D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.3109/00365528209182066`
│   │   inner_content: `10.3109/00365528209182066`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy__vitamin__ D3 treatment. Gastroenterology. (1982) 83:97-102. doi: 10.1016/S0016-5085(82)80291-6`
│   inner_content: `Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy__vitamin__ D3 treatment. Gastroenterology. (1982) 83:97-102. doi: 10.1016/S0016-5085(82)80291-6`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy`
│   │   inner_content: `Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy`
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D3 treatment. Gastroenterology. (1982) 83:97-102. `
│   │   inner_content: ` D3 treatment. Gastroenterology. (1982) 83:97-102. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1016/S0016-5085(82)80291-6`
│   │   inner_content: `10.1016/S0016-5085(82)80291-6`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. __vitamin__ D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. doi: 10.1007/s40519-016-0312-6`
│   inner_content: `Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. __vitamin__ D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. doi: 10.1007/s40519-016-0312-6`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. `
│   │   inner_content: `Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. `
│   │   inner_content: ` D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. `
│   ├── DoiLinkNode
│   │   full_match: `doi: 10.1007/s40519-016-0312-6`
│   │   inner_content: `10.1007/s40519-016-0312-6`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gatti D, Idolazzi L, Fassio A. __vitamin__ D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.`
│   inner_content: `Gatti D, Idolazzi L, Fassio A. __vitamin__ D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gatti D, Idolazzi L, Fassio A. `
│   │   inner_content: `Gatti D, Idolazzi L, Fassio A. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.`
│   │   inner_content: ` D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. __vitamin__ D supplementation to prevent acute respiratory tract infections:\tsystematic review and meta-analysis of individual participant data. BMJ. (2017)\t356:i6583. doi:\t10.1136/bmj.i6583`
│   inner_content: `Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. __vitamin__ D supplementation to prevent acute respiratory tract infections:\tsystematic review and meta-analysis of individual participant data. BMJ. (2017)\t356:i6583. doi:\t10.1136/bmj.i6583`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. `
│   │   inner_content: `Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin__`
│   │   inner_content: `vitamin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin`
│   │   │   inner_content: `vitamin`
│   ├── TextNode
│   │   full_match: ` D supplementation to prevent acute respiratory tract infections:\tsystematic review and meta-analysis of individual participant data. BMJ. (2017)\t356:i6583. `
│   │   inner_content: ` D supplementation to prevent acute respiratory tract infections:\tsystematic review and meta-analysis of individual participant data. BMJ. (2017)\t356:i6583. `
│   ├── DoiLinkNode
│   │   full_match: `doi:\t10.1136/bmj.i6583`
│   │   inner_content: `10.1136/bmj.i6583`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Vitamin D nanoemulsion appears to also have similar good bio-availabilty and faster response`
│   inner_content: `Vitamin D nanoemulsion appears to also have similar good bio-availabilty and faster response`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D nanoemulsion appears to also have similar good bio-availabilty and faster response`
│   │   inner_content: `Vitamin D nanoemulsion appears to also have similar good bio-availabilty and faster response`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Nanoemulsion Vitamin D is faster and better - many studies))`
│   inner_content: `((Nanoemulsion Vitamin D is faster and better - many studies))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Nanoemulsion Vitamin D is faster and better - many studies))`
│   │   inner_content: `Nanoemulsion Vitamin D is faster and better - many studies`
│   │   page: `Nanoemulsion Vitamin D is faster and better - many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Nanoemulsion Vitamin D is faster and better - many studies`
│   │   │   inner_content: `Nanoemulsion Vitamin D is faster and better - many studies`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019))`
│   inner_content: `((Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019))`
│   │   inner_content: `Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019`
│   │   page: `Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019`
│   │   │   inner_content: `Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023))`
│   inner_content: `((Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023))`
│   │   inner_content: `Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023`
│   │   page: `Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023`
│   │   │   inner_content: `Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Nanoemulsion Vitamin D may be a substantially better form))  has the following comparison`
│   inner_content: `((Nanoemulsion Vitamin D may be a substantially better form))  has the following comparison`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Nanoemulsion Vitamin D may be a substantially better form))`
│   │   inner_content: `Nanoemulsion Vitamin D may be a substantially better form`
│   │   page: `Nanoemulsion Vitamin D may be a substantially better form`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Nanoemulsion Vitamin D may be a substantially better form`
│   │   │   inner_content: `Nanoemulsion Vitamin D may be a substantially better form`
│   ├── TextNode
│   │   full_match: `  has the following comparison`
│   │   inner_content: `  has the following comparison`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IndentNode
│   full_match: `+{include page=&quot;Nanoemulsion Vitamin D may be a substantially better form&quot; start=&quot;~tc~ start2 ~/tc~&quot; stop=&quot;~tc~ end2 ~/tc~&quot;}`
│   inner_content: `{include page=&quot;Nanoemulsion Vitamin D may be a substantially better form&quot; start=&quot;~tc~ start2 ~/tc~&quot; stop=&quot;~tc~ end2 ~/tc~&quot;}`
│   level: `1`
│   children:
│   ├── IncludeNode
│   │   full_match: `{include page=&quot;Nanoemulsion Vitamin D may be a substantially better form&quot; start=&quot;~tc~ start2 ~/tc~&quot; stop=&quot;~tc~ end2 ~/tc~&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  page=&quot;Nanoemulsion Vitamin D may be a substantially better form&quot; start=&quot;~tc~ start2 ~/tc~&quot; stop=&quot;~tc~ end2 ~/tc~&quot;
│   │   │   page: Nanoemulsion Vitamin D may be a substantially better form
│   │   │   start: ~tc~ start2 ~/tc~
│   │   │   stop: ~tc~ end2 ~/tc~
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: ``
│   │   │   inner_content: ``

Original Tiki:
-------------
{img type=&quot;attId&quot; attId=&quot;21032&quot; width=&quot;500&quot;}
Note: Horizontal axis IS NOT linear

{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!A comparative absorption study of sucrosomial® orodispersible vitamin D3 supplementation vs. a reference chewable tablet and soft gel capsule vitamin D3 in improving circulatory 25(OH)D levels in healthy adults with vitamin D deficiency—Results from a prospective randomized clinical trial
Front. Nutr., 17 August 2023 Volume 10 - 2023 | https://doi.org/10.3389/fnut.2023.1221685
Aasiya Bano1† Saida Abrar2† Elisa Brilli3 Germano Tarantino3 Ali Akbar Bugti4 Marco Fabbrini5 Gabriele Conti5 Silvia Turroni5 Mahroo Bugti6 Fauzia Afridi7 Shah Mureed8 Hakeem Zada9 Ikram Din Ujjan10 Saadia Ashraf11 Aamir Ghafoor12 Saeed Khan13 Amjad Khan14,15*

__Second Trial__
{img type=&quot;attId&quot; attId=&quot;21033&quot; width=&quot;500&quot;}
Note: Horizontal axis IS NOT linear
Objective: We aimed to compare the absorption of an innovative phospholipids-sucrester matrix biodelivery vehicle-based (sucrosomial®) orodispersible Vit D3 preparation against a reference chewable tablet and soft gel capsule (SGC) Vit D3 formulations in Vit D-deficient healthy adults.

Methods: In study 1, 25 subjects were randomized to receive a weekly single dose of 200,000 IU of sucrosomial® Vit D3 (n = 12) or chewable tablet Vit D3 (n = 13) for 3 weeks. 
In study 2, 20 subjects were randomized to receive a single dose of 200,000 IU every other week of sucrosomial® Vit D3 (n = 10) or SGC Vit D3 (n = 10) for 6 weeks. Circulatory 25-hydroxyvitamin D3 [25(OH)D] levels were reassessed after 2, 3, and 6 weeks in study 1 and after 4 and 6 weeks in study 2.

Results: In study 1, after 2 weeks, circulatory 25(OH)D levels increased significantly in both Vit D3 treatment groups (p &lt; 0.0001) but improved markedly in the sucrosomial® Vit D3 group, with no further considerable change after 3 and 6 weeks in both groups. Overall, at all three follow-ups, sucrosomial® Vit D3 treatment achieved significantly higher and sustained 25(OH)D levels (p &lt; 0.001). In study 2, after 4 weeks, both Vit D3 treatment groups showed significant improvement in circulatory 25(OH)D levels (p &lt; 0.0001) but substantially higher in the sucrosomial® group with statistically significant differences between the two treatment groups (p = 0.02). At the 6-week follow-up, only subjects in the sucrosomial® Vit D3 group showed a further increase in circulatory 25(OH)D levels (p = 0.049), but no further significant changes in the levels of the SGC Vit D3 group (p = 0.062), showing a statistically significant difference between the two treatment groups (p = 0.002). The Vit D3 treatment was well tolerated by all participants, and no treatment-emergent effects or serious adverse events were reported.

Conclusion: Our results suggest that the sucrosomial® Vit D3 preparation absorbs efficiently in the GI system, achieving adequately higher and sustained circulatory Vit D levels in VDD, and thus can effectively contribute to the body protection against VDD-associated health conditions.

Clinical trial registration: clinicaltrials.gov, identifier: NCT05706259.
{FONT(size=&quot;18&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;21031&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!!55 References
#Bikle Daniel D. __vitamin__ D metabolism, mechanism of action, and clinical applications. ChemBiol (2014) 21:319-29. doi: 10.1016/j.chembiol.2013.12.016
#Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J. Silva DDd, et al. __vitamin__ D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of __vitamin__ D and its metabolites. Crit Rev Clin Lab Sci. (2022) 59:517-54. doi: 10.1080/10408363.2022.2070595
#Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. __vitamin__ D: modulator of the immune system. Curr Opin Pharmacol. (2010) 10:482-96. doi: 10.1016/j.coph.2010.04.001
#Lagishetty V, Liu NQ, Hewison M. __vitamin__ D metabolism and innate immunity. Mol Cell Endocrinol. (2011) 347:97-105. doi: 10.1016/j.mce.2011.04.015
#Pludowski P, Holick MF, Grant WB, Konstantynowicz J, Mascarenhas MR, Haq A, et al. __vitamin__ D supplementation guidelines. J Steroid Biochem Mol Biol. (2018) 175:125-35. doi: 10.1016/j.jsbmb.2017.01.021
#Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with __vitamin__ D deficiency. Nutrition. (2021) 84:111106. doi: 10.1016/j.nut.2020.111106
#Ao T, Kikuta J, Ishii M. The effects of __vitamin__ D on immune system and inflammatory diseases. Biomolecules. (2021) 11:624. doi: 10.3390/biom11111624
#Charoenngam N, Holick MF. Immunologic effects of__vitamin__ D on human health and disease. Nutrients. (2020) 12:97. doi: 10.3390/nu12072097
#Gois PHF, Ferreira D, Olenski S, Seguro AC. __vitamin__ D and infectious diseases:	simple bystander or contributing factor? Nutrients. (2017) 9:651. doi: 10.3390/nu9070651
#Iqtadar S, Khan A, Mumtaz SU, Livingstone S, Chaudhry MNA, Raza N, et al. __vitamin__ D deficiency (VDD) and susceptibility towards severe dengue fever-a prospective cross-sectional study of hospitalized dengue fever patients from Lahore, Pakistan. TropMedInfectDis. (2023) 8:43. doi: 10.3390/tropicalmed8010043
#L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. __vitamin__ D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus. (2021) 5:e10405. doi: 10.1002/jbm4.10405
#Thacher TD, Clarke BL. __vitamin__ D insufficiency. Mayo ClinProc. (2011) 86:50­60. doi: 10.4065/mcp.2010.0567
#Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A. et al. __vitamin__ D deficiency 20: an update on the current status worldwide. EurJClin Nutr. (2020) 74:1498-513. doi: 10.1038/s41430-020-0558-y
#Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-Ferrari HA, Obermayer­Pietsch B, Bianchi ML, et al. Current __vitamin__ D status in european and middle east countries and strategies to prevent __vitamin__ d deficiency: a position statement of the european calcified tissue society. Eur J Endocrinol. (2019) 180:P23- 54. doi: 10.1530/EJE-18-0736
#Holick MF. __vitamin__ D deficiency. N Engl J Med. (2007) 357:266­81. doi: 10.1056/NEJMra070553
#Nair R, Maseeh A. __vitamin__ D: the “sunshine&quot; __vitamin__. J Pharmacol Pharmacother. (2012) 3:118-26. doi: 10.4103/0976-500X.95506
#Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, et al. Prevalence of __vitamin__ D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. (2016) 9:329-38. doi: 10.1586/17512433.2016.1122519
#Macdonald HM, Mavroeidi A, Fraser WD, Darling AL, Black AJ, Aucott L, et al. Sunlight and dietary contributions to the seasonal __vitamin__ D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? Osteoporos Int. (2011) 22:2461-72. doi: 10.1007/s00198-010-1467-z
#Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. __vitamin__ D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. (1985) 42:644-9. doi: 10.1093/ajcn/42.4.644
#Cupone IE, Dellera E, Marra F, Giori AM. Development and characterization of an orodispersible film for __vitamin__ d3 supplementation. Molecules. (2020) 25:851. doi: 10.3390/molecules25245851
#Fassio A, Adami G, Rossini M, Giollo A, Caimmi C, Bixio R, et al. Pharmacokinetics of oral cholecalciferol in healthy subjects with __vitamin__ d deficiency: a randomized open-label study. Nutrients. (2020) 12:53. doi: 10.3390/nu12061553
#Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, et al. Prospective, randomized, double-blind, parallel-group, comparative effectiveness clinical trial comparing a powder vehicle compound of __vitamin__ D with an oil vehicle compound in adults with cystic fibrosis. JPENJParenter Enteral Nutr. (2017) 41:952­8. doi: 10.1177/0148607116629673
#Jetter A, Egli A, Dawson-Hughes B, Staehelin HB, Stoecklin E, Goessl R, et al. Pharmacokinetics of oral __vitamin__ D(3) and calcifediol. Bone. (2014) 59:14­9. doi: 10.1016/j.bone.2013.10.014
#Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P. Pharmacokinetics of a new pharmaceutical form of __vitamin__ D3 100,000 IU in soft capsule. Nutrients. (2019) 11:703. doi: 10.3390/nu11030703
#Radicioni M, Caverzasio C, Rovati S, Giori AM, Cupone I, Marra F, et al. Comparative bioavailability study of a new __vitamin__ D3 orodispersible film versus a marketed oral solution in healthy volunteers. Clin Drug Investig. (2022) 42:151 — 61. doi: 10.1007/s40261 -021-01113-7
#Satia MC, Mukim AG, Tibrewala KD, Bhavsar MS, A. randomized two way cross over study for comparison of absorption of __vitamin__ D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption. NutrJ. (2015) 14:114. doi: 10.1186/s12937-015-0105-1
#Wagner CL, Shary JR, Nietert PJ, Wahlquist AE, Ebeling MD, Hollis BW. Bioequivalence studies of __vitamin__ D gummies and tablets in healthy adults: results of a cross-over study. Nutrients. (2019) 11:17. doi: 10.3390/nu11051023
#Maurya VK, Aggarwal M. Factors influencing the absorption of __vitamin__ D in GIT: an overview. J Food Sci Technol. (2017) 54:3753­65. doi: 10.1007/s13197-017-2840-0
#Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. __sucrosomial__(®) iron: a new generation iron for improving oral supplementation. Pharmaceuticals. (2018) 11:97. doi: 10.3390/ph11040097
#Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc Series B Stat Methodol. (2010) 72:405-16. doi: 10.1111/j.1467-9868.2010.00746.x
#R Core Team. R: A Language and Environmentfor Statistical Computing. (2020). Available online at: https://www.r-project.org/ (accessed June 11, 2023).
#Wickham H. Elegant Graphics for Data Analysis. New York, NY: Springer Cham (2016).
#Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. __vitamin__ D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. (1998) 8:222-30. doi: 10.1007/s001980050058
#Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G. __sucrosomial__ technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood. (2016) 128:3618. doi: 10.1182/blood.V128.22.3618.3618
#Du M, Chang C, Zhang X, Zhang Y, Radford MJ, Gahler RJ, et al. Designing __vitamin__ D3 formulations: an in vitro investigation using a novel micellar delivery system. Nutraceuticals. (2023) 3:290-305. doi: 10.3390/nutraceuticals3020023
#Fabiano A, Brilli E, Mattii L, Testai L, Moscato S, Citi V, et al. Ex Vivo and in Vivo study of __sucrosomial__(®) iron intestinal absorption and bioavailability. Int J Mol Sci. (2018) 19:722. doi: 10.3390/ijms19092722
#Takaishi N, Satsu H, Shimizu M. Enhanced daunomycin accumulation in human intestinal Caco-2 cells from non-ionic food emulsifiers unrelated to the p-glycoprotein inhibitory mechanism. Biosci Biotechnol Biochem. (2006) 70:2703­11. doi: 10.1271/bbb.60306
#Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D, L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. (1998) 15:107-19. doi: 10.3109/02652049809006840
#Bertani L, Trico D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, et al. Oral __sucrosomial__ iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients. (2021) 13:2. doi: 10.3390/nu130 20608
#Narang NC, Sharma J, Baba S. Sublingual mucosa as a route for systemic drug delivery. JPharmacol Pharmacother. (2011) 3:118-26.
#Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25- hydroxy__vitamin__ D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr. (1979) 94:38-42. doi: 10.1016/S0022-3476(79) 80346-7
#Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. __vitamin__ D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology. (1982) 83:1252­8. doi: 10.1016/S0016-5085(82)80135-2
#Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B. Osteomalacia after small-intestinal resection. Lancet. (1978) 1:9-12. doi: 10.1016/S0140-6736(78) 90358-6
#Markestad T, Aksnes L, Finne PH, Aarskog D. Decreased __vitamin__ D absorption after limited jejunal resection in a premature infant. J Pediatr. (1982) 101:1001­8. doi: 10.1016/S0022-3476(82)80031-0
#Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25- hydroxylation of __vitamin__ D in patients with primary biliary cirrhosis. Scand J Gastroenterol. (1982) 17:349-55. doi: 10.3109/00365528209182066
#Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy__vitamin__ D3 treatment. Gastroenterology. (1982) 83:97-102. doi: 10.1016/S0016-5085(82)80291-6
#Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. __vitamin__ D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects Eating and Weight Disorders-Studies on Anorexia. Bulimia Obesity. (2017) 22:27­41. doi: 10.1007/s40519-016-0312-6
#Gatti D, Idolazzi L, Fassio A. __vitamin__ D: not just bone, but also immunity. MinervaMed. (2016) 107:452-60.
#Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. __vitamin__ D supplementation to prevent acute respiratory tract infections:	systematic review and meta-analysis of individual participant data. BMJ. (2017)	356:i6583. doi:	10.1136/bmj.i6583
---
!!!!Vitamin D nanoemulsion appears to also have similar good bio-availabilty and faster response
*((Nanoemulsion Vitamin D is faster and better - many studies))
*((Bioavailability of nanoemulsion formulations of Vitamin D3 – Nov 2019))
*((Vitamin D: liposomal and nanoemulsion forms - Chat-GPT Dec 2023))
*((Nanoemulsion Vitamin D may be a substantially better form))  has the following comparison
+{include page=&quot;Nanoemulsion Vitamin D may be a substantially better form&quot; start=&quot;~tc~ start2 ~/tc~&quot; stop=&quot;~tc~ end2 ~/tc~&quot;}
</code>
</pre>
